Loading…
Enhanced formation of advanced oxidation protein products in IBD
Background: Advanced oxidation protein products (AOPPs) are new protein markers of oxidative stress with pro‐inflammatory properties, accumulated in many pathological conditions. The issue of their enhanced formation in IBD has not been addressed yet. Methods: The concentration of relative AOPPs (rA...
Saved in:
Published in: | Inflammatory bowel diseases 2008-06, Vol.14 (6), p.794-802 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4563-73f3dc0adf7e49cbe9d250d34154f977de5d69bc1d51396b734ac22b7ca435ae3 |
---|---|
cites | cdi_FETCH-LOGICAL-c4563-73f3dc0adf7e49cbe9d250d34154f977de5d69bc1d51396b734ac22b7ca435ae3 |
container_end_page | 802 |
container_issue | 6 |
container_start_page | 794 |
container_title | Inflammatory bowel diseases |
container_volume | 14 |
creator | Krzystek‐Korpacka, Malgorzata Neubauer, Katarzyna Berdowska, Izabela Boehm, Dorota Zielinski, Bogdan Petryszyn, Pawel Terlecki, Grzegorz Paradowski, Leszek Gamian, Andrzej |
description | Background: Advanced oxidation protein products (AOPPs) are new protein markers of oxidative stress with pro‐inflammatory properties, accumulated in many pathological conditions. The issue of their enhanced formation in IBD has not been addressed yet.
Methods: The concentration of relative AOPPs (rAOPP; concentration of AOPPs divided by albumin level) were measured in 68 subjects with ulcerative colitis (UC), 50 subjects with Crohn's disease (CD) and 45 healthy volunteers, and related to disease phenotype, clinical and biochemical activity, and therapeutic strategy. Diagnostic utility of rAOPP was evaluated by ROC analysis.
Results: In comparison with controls (1.367 μmol/g), rAOPP were increased in inactive (1.778 μmol/g, P = 0.053) and active (1.895 μmol/g, P = 0.013) UC and in active (1.847 μmol/g, P = 0.003) CD. In CD, but not UC, rAOPP correlated with disease activity (r = 0.42, P = 0.013). Significant correlations with the inflammatory/malnutrition indices‐erythrocyte sedimentation rate (ESR) (r = 0.53), leukocytes (r = 0.33), platelets (r = 0.38), IL‐6 (r = 0.36), and transferrin (r = −0.35) were demonstrated in CD. In UC, rAOPP correlated only with ESR (r = 0.35) and IL‐6 (r = 0.30). Instead, associations with antioxidant dismutase (r = 0.29) and catalase (r = 0.22) were observed. The diagnostic power of rAOPP in discriminating diseased from non‐diseased subjects was less than that of C‐reactive protein (CRP). Simultaneous determination of rAOPP and CRP did not significantly improve the power of single CRP determination.
Conclusions: IBD was associated with enhanced formation of AOPP, which differed between C and UC with respect to the relationship between rAOPP and disease activity, inflammatory and antioxidant response. These differences may reflect divergent ways that oxidative stress develops in CD and UC. The diagnostic power of rAOPP was insufficient for its clinical application.
(Inflamm Bowel Dis 2008) |
doi_str_mv | 10.1002/ibd.20383 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_902333841</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>902333841</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4563-73f3dc0adf7e49cbe9d250d34154f977de5d69bc1d51396b734ac22b7ca435ae3</originalsourceid><addsrcrecordid>eNp9kEFLwzAUx4Mobk4PfgHpSfHQLelLmubmnFMHAy96DmmSYqVtZtOq-_bGdeBJeYf3-PPj_-CH0DnBU4JxMitzM00wZHCAxoRBGtOM0sNwY57FWIhshE68fwtoGHGMRiRLCHCMx-hm2byqRlsTFa6tVVe6JnJFpMzHkLqv0gzppnWdLXfb9LrzUbhXt3en6KhQlbdn-z1BL_fL58VjvH56WC3m61hTlkLMoQCjsTIFt1To3AqTMGyAEkYLwbmxzKQi18QwAiLNOVClkyTnWlFgysIEXQ294f97b30n69JrW1Wqsa73UuAEADJKAnn5L5mKoEEwGsDrAdSt8761hdy0Za3arSRY_oiVQazciQ3sxb60z2trfsm9yQDMBuCzrOz27yYZnA2V31J7gP8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69202954</pqid></control><display><type>article</type><title>Enhanced formation of advanced oxidation protein products in IBD</title><source>Oxford Journals Online</source><creator>Krzystek‐Korpacka, Malgorzata ; Neubauer, Katarzyna ; Berdowska, Izabela ; Boehm, Dorota ; Zielinski, Bogdan ; Petryszyn, Pawel ; Terlecki, Grzegorz ; Paradowski, Leszek ; Gamian, Andrzej</creator><creatorcontrib>Krzystek‐Korpacka, Malgorzata ; Neubauer, Katarzyna ; Berdowska, Izabela ; Boehm, Dorota ; Zielinski, Bogdan ; Petryszyn, Pawel ; Terlecki, Grzegorz ; Paradowski, Leszek ; Gamian, Andrzej</creatorcontrib><description>Background: Advanced oxidation protein products (AOPPs) are new protein markers of oxidative stress with pro‐inflammatory properties, accumulated in many pathological conditions. The issue of their enhanced formation in IBD has not been addressed yet.
Methods: The concentration of relative AOPPs (rAOPP; concentration of AOPPs divided by albumin level) were measured in 68 subjects with ulcerative colitis (UC), 50 subjects with Crohn's disease (CD) and 45 healthy volunteers, and related to disease phenotype, clinical and biochemical activity, and therapeutic strategy. Diagnostic utility of rAOPP was evaluated by ROC analysis.
Results: In comparison with controls (1.367 μmol/g), rAOPP were increased in inactive (1.778 μmol/g, P = 0.053) and active (1.895 μmol/g, P = 0.013) UC and in active (1.847 μmol/g, P = 0.003) CD. In CD, but not UC, rAOPP correlated with disease activity (r = 0.42, P = 0.013). Significant correlations with the inflammatory/malnutrition indices‐erythrocyte sedimentation rate (ESR) (r = 0.53), leukocytes (r = 0.33), platelets (r = 0.38), IL‐6 (r = 0.36), and transferrin (r = −0.35) were demonstrated in CD. In UC, rAOPP correlated only with ESR (r = 0.35) and IL‐6 (r = 0.30). Instead, associations with antioxidant dismutase (r = 0.29) and catalase (r = 0.22) were observed. The diagnostic power of rAOPP in discriminating diseased from non‐diseased subjects was less than that of C‐reactive protein (CRP). Simultaneous determination of rAOPP and CRP did not significantly improve the power of single CRP determination.
Conclusions: IBD was associated with enhanced formation of AOPP, which differed between C and UC with respect to the relationship between rAOPP and disease activity, inflammatory and antioxidant response. These differences may reflect divergent ways that oxidative stress develops in CD and UC. The diagnostic power of rAOPP was insufficient for its clinical application.
(Inflamm Bowel Dis 2008)</description><identifier>ISSN: 1078-0998</identifier><identifier>EISSN: 1536-4844</identifier><identifier>DOI: 10.1002/ibd.20383</identifier><identifier>PMID: 18213700</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adolescent ; Adult ; advanced oxidation protein products (AOPPs) ; Aged ; Albumin ; Antioxidants ; Biomarkers - blood ; Blood Proteins - metabolism ; C-reactive protein ; C-Reactive Protein - analysis ; Catalase ; Colitis, Ulcerative - blood ; Crohn Disease - blood ; Crohn's disease ; Female ; Humans ; Inflammation - blood ; inflammatory bowel disease (IBD) ; Inflammatory bowel diseases ; Inflammatory Bowel Diseases - blood ; Inflammatory Bowel Diseases - diagnosis ; Interleukin 6 ; Interleukin-6 - blood ; Intestine ; Leukocytes ; Lipids - blood ; Male ; Malnutrition ; Malnutrition - blood ; Middle Aged ; Oxidation-Reduction ; Oxidative stress ; Oxidative Stress - physiology ; Platelets ; ROC Curve ; Sedimentation ; Therapeutic applications ; Transferrin ; Transferrin - analysis ; Ulcerative colitis</subject><ispartof>Inflammatory bowel diseases, 2008-06, Vol.14 (6), p.794-802</ispartof><rights>Copyright © 2008 Crohn's & Colitis Foundation of America, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4563-73f3dc0adf7e49cbe9d250d34154f977de5d69bc1d51396b734ac22b7ca435ae3</citedby><cites>FETCH-LOGICAL-c4563-73f3dc0adf7e49cbe9d250d34154f977de5d69bc1d51396b734ac22b7ca435ae3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18213700$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Krzystek‐Korpacka, Malgorzata</creatorcontrib><creatorcontrib>Neubauer, Katarzyna</creatorcontrib><creatorcontrib>Berdowska, Izabela</creatorcontrib><creatorcontrib>Boehm, Dorota</creatorcontrib><creatorcontrib>Zielinski, Bogdan</creatorcontrib><creatorcontrib>Petryszyn, Pawel</creatorcontrib><creatorcontrib>Terlecki, Grzegorz</creatorcontrib><creatorcontrib>Paradowski, Leszek</creatorcontrib><creatorcontrib>Gamian, Andrzej</creatorcontrib><title>Enhanced formation of advanced oxidation protein products in IBD</title><title>Inflammatory bowel diseases</title><addtitle>Inflamm Bowel Dis</addtitle><description>Background: Advanced oxidation protein products (AOPPs) are new protein markers of oxidative stress with pro‐inflammatory properties, accumulated in many pathological conditions. The issue of their enhanced formation in IBD has not been addressed yet.
Methods: The concentration of relative AOPPs (rAOPP; concentration of AOPPs divided by albumin level) were measured in 68 subjects with ulcerative colitis (UC), 50 subjects with Crohn's disease (CD) and 45 healthy volunteers, and related to disease phenotype, clinical and biochemical activity, and therapeutic strategy. Diagnostic utility of rAOPP was evaluated by ROC analysis.
Results: In comparison with controls (1.367 μmol/g), rAOPP were increased in inactive (1.778 μmol/g, P = 0.053) and active (1.895 μmol/g, P = 0.013) UC and in active (1.847 μmol/g, P = 0.003) CD. In CD, but not UC, rAOPP correlated with disease activity (r = 0.42, P = 0.013). Significant correlations with the inflammatory/malnutrition indices‐erythrocyte sedimentation rate (ESR) (r = 0.53), leukocytes (r = 0.33), platelets (r = 0.38), IL‐6 (r = 0.36), and transferrin (r = −0.35) were demonstrated in CD. In UC, rAOPP correlated only with ESR (r = 0.35) and IL‐6 (r = 0.30). Instead, associations with antioxidant dismutase (r = 0.29) and catalase (r = 0.22) were observed. The diagnostic power of rAOPP in discriminating diseased from non‐diseased subjects was less than that of C‐reactive protein (CRP). Simultaneous determination of rAOPP and CRP did not significantly improve the power of single CRP determination.
Conclusions: IBD was associated with enhanced formation of AOPP, which differed between C and UC with respect to the relationship between rAOPP and disease activity, inflammatory and antioxidant response. These differences may reflect divergent ways that oxidative stress develops in CD and UC. The diagnostic power of rAOPP was insufficient for its clinical application.
(Inflamm Bowel Dis 2008)</description><subject>Adolescent</subject><subject>Adult</subject><subject>advanced oxidation protein products (AOPPs)</subject><subject>Aged</subject><subject>Albumin</subject><subject>Antioxidants</subject><subject>Biomarkers - blood</subject><subject>Blood Proteins - metabolism</subject><subject>C-reactive protein</subject><subject>C-Reactive Protein - analysis</subject><subject>Catalase</subject><subject>Colitis, Ulcerative - blood</subject><subject>Crohn Disease - blood</subject><subject>Crohn's disease</subject><subject>Female</subject><subject>Humans</subject><subject>Inflammation - blood</subject><subject>inflammatory bowel disease (IBD)</subject><subject>Inflammatory bowel diseases</subject><subject>Inflammatory Bowel Diseases - blood</subject><subject>Inflammatory Bowel Diseases - diagnosis</subject><subject>Interleukin 6</subject><subject>Interleukin-6 - blood</subject><subject>Intestine</subject><subject>Leukocytes</subject><subject>Lipids - blood</subject><subject>Male</subject><subject>Malnutrition</subject><subject>Malnutrition - blood</subject><subject>Middle Aged</subject><subject>Oxidation-Reduction</subject><subject>Oxidative stress</subject><subject>Oxidative Stress - physiology</subject><subject>Platelets</subject><subject>ROC Curve</subject><subject>Sedimentation</subject><subject>Therapeutic applications</subject><subject>Transferrin</subject><subject>Transferrin - analysis</subject><subject>Ulcerative colitis</subject><issn>1078-0998</issn><issn>1536-4844</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNp9kEFLwzAUx4Mobk4PfgHpSfHQLelLmubmnFMHAy96DmmSYqVtZtOq-_bGdeBJeYf3-PPj_-CH0DnBU4JxMitzM00wZHCAxoRBGtOM0sNwY57FWIhshE68fwtoGHGMRiRLCHCMx-hm2byqRlsTFa6tVVe6JnJFpMzHkLqv0gzppnWdLXfb9LrzUbhXt3en6KhQlbdn-z1BL_fL58VjvH56WC3m61hTlkLMoQCjsTIFt1To3AqTMGyAEkYLwbmxzKQi18QwAiLNOVClkyTnWlFgysIEXQ294f97b30n69JrW1Wqsa73UuAEADJKAnn5L5mKoEEwGsDrAdSt8761hdy0Za3arSRY_oiVQazciQ3sxb60z2trfsm9yQDMBuCzrOz27yYZnA2V31J7gP8</recordid><startdate>200806</startdate><enddate>200806</enddate><creator>Krzystek‐Korpacka, Malgorzata</creator><creator>Neubauer, Katarzyna</creator><creator>Berdowska, Izabela</creator><creator>Boehm, Dorota</creator><creator>Zielinski, Bogdan</creator><creator>Petryszyn, Pawel</creator><creator>Terlecki, Grzegorz</creator><creator>Paradowski, Leszek</creator><creator>Gamian, Andrzej</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>200806</creationdate><title>Enhanced formation of advanced oxidation protein products in IBD</title><author>Krzystek‐Korpacka, Malgorzata ; Neubauer, Katarzyna ; Berdowska, Izabela ; Boehm, Dorota ; Zielinski, Bogdan ; Petryszyn, Pawel ; Terlecki, Grzegorz ; Paradowski, Leszek ; Gamian, Andrzej</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4563-73f3dc0adf7e49cbe9d250d34154f977de5d69bc1d51396b734ac22b7ca435ae3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>advanced oxidation protein products (AOPPs)</topic><topic>Aged</topic><topic>Albumin</topic><topic>Antioxidants</topic><topic>Biomarkers - blood</topic><topic>Blood Proteins - metabolism</topic><topic>C-reactive protein</topic><topic>C-Reactive Protein - analysis</topic><topic>Catalase</topic><topic>Colitis, Ulcerative - blood</topic><topic>Crohn Disease - blood</topic><topic>Crohn's disease</topic><topic>Female</topic><topic>Humans</topic><topic>Inflammation - blood</topic><topic>inflammatory bowel disease (IBD)</topic><topic>Inflammatory bowel diseases</topic><topic>Inflammatory Bowel Diseases - blood</topic><topic>Inflammatory Bowel Diseases - diagnosis</topic><topic>Interleukin 6</topic><topic>Interleukin-6 - blood</topic><topic>Intestine</topic><topic>Leukocytes</topic><topic>Lipids - blood</topic><topic>Male</topic><topic>Malnutrition</topic><topic>Malnutrition - blood</topic><topic>Middle Aged</topic><topic>Oxidation-Reduction</topic><topic>Oxidative stress</topic><topic>Oxidative Stress - physiology</topic><topic>Platelets</topic><topic>ROC Curve</topic><topic>Sedimentation</topic><topic>Therapeutic applications</topic><topic>Transferrin</topic><topic>Transferrin - analysis</topic><topic>Ulcerative colitis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Krzystek‐Korpacka, Malgorzata</creatorcontrib><creatorcontrib>Neubauer, Katarzyna</creatorcontrib><creatorcontrib>Berdowska, Izabela</creatorcontrib><creatorcontrib>Boehm, Dorota</creatorcontrib><creatorcontrib>Zielinski, Bogdan</creatorcontrib><creatorcontrib>Petryszyn, Pawel</creatorcontrib><creatorcontrib>Terlecki, Grzegorz</creatorcontrib><creatorcontrib>Paradowski, Leszek</creatorcontrib><creatorcontrib>Gamian, Andrzej</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Inflammatory bowel diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Krzystek‐Korpacka, Malgorzata</au><au>Neubauer, Katarzyna</au><au>Berdowska, Izabela</au><au>Boehm, Dorota</au><au>Zielinski, Bogdan</au><au>Petryszyn, Pawel</au><au>Terlecki, Grzegorz</au><au>Paradowski, Leszek</au><au>Gamian, Andrzej</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Enhanced formation of advanced oxidation protein products in IBD</atitle><jtitle>Inflammatory bowel diseases</jtitle><addtitle>Inflamm Bowel Dis</addtitle><date>2008-06</date><risdate>2008</risdate><volume>14</volume><issue>6</issue><spage>794</spage><epage>802</epage><pages>794-802</pages><issn>1078-0998</issn><eissn>1536-4844</eissn><abstract>Background: Advanced oxidation protein products (AOPPs) are new protein markers of oxidative stress with pro‐inflammatory properties, accumulated in many pathological conditions. The issue of their enhanced formation in IBD has not been addressed yet.
Methods: The concentration of relative AOPPs (rAOPP; concentration of AOPPs divided by albumin level) were measured in 68 subjects with ulcerative colitis (UC), 50 subjects with Crohn's disease (CD) and 45 healthy volunteers, and related to disease phenotype, clinical and biochemical activity, and therapeutic strategy. Diagnostic utility of rAOPP was evaluated by ROC analysis.
Results: In comparison with controls (1.367 μmol/g), rAOPP were increased in inactive (1.778 μmol/g, P = 0.053) and active (1.895 μmol/g, P = 0.013) UC and in active (1.847 μmol/g, P = 0.003) CD. In CD, but not UC, rAOPP correlated with disease activity (r = 0.42, P = 0.013). Significant correlations with the inflammatory/malnutrition indices‐erythrocyte sedimentation rate (ESR) (r = 0.53), leukocytes (r = 0.33), platelets (r = 0.38), IL‐6 (r = 0.36), and transferrin (r = −0.35) were demonstrated in CD. In UC, rAOPP correlated only with ESR (r = 0.35) and IL‐6 (r = 0.30). Instead, associations with antioxidant dismutase (r = 0.29) and catalase (r = 0.22) were observed. The diagnostic power of rAOPP in discriminating diseased from non‐diseased subjects was less than that of C‐reactive protein (CRP). Simultaneous determination of rAOPP and CRP did not significantly improve the power of single CRP determination.
Conclusions: IBD was associated with enhanced formation of AOPP, which differed between C and UC with respect to the relationship between rAOPP and disease activity, inflammatory and antioxidant response. These differences may reflect divergent ways that oxidative stress develops in CD and UC. The diagnostic power of rAOPP was insufficient for its clinical application.
(Inflamm Bowel Dis 2008)</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>18213700</pmid><doi>10.1002/ibd.20383</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1078-0998 |
ispartof | Inflammatory bowel diseases, 2008-06, Vol.14 (6), p.794-802 |
issn | 1078-0998 1536-4844 |
language | eng |
recordid | cdi_proquest_miscellaneous_902333841 |
source | Oxford Journals Online |
subjects | Adolescent Adult advanced oxidation protein products (AOPPs) Aged Albumin Antioxidants Biomarkers - blood Blood Proteins - metabolism C-reactive protein C-Reactive Protein - analysis Catalase Colitis, Ulcerative - blood Crohn Disease - blood Crohn's disease Female Humans Inflammation - blood inflammatory bowel disease (IBD) Inflammatory bowel diseases Inflammatory Bowel Diseases - blood Inflammatory Bowel Diseases - diagnosis Interleukin 6 Interleukin-6 - blood Intestine Leukocytes Lipids - blood Male Malnutrition Malnutrition - blood Middle Aged Oxidation-Reduction Oxidative stress Oxidative Stress - physiology Platelets ROC Curve Sedimentation Therapeutic applications Transferrin Transferrin - analysis Ulcerative colitis |
title | Enhanced formation of advanced oxidation protein products in IBD |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T15%3A24%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Enhanced%20formation%20of%20advanced%20oxidation%20protein%20products%20in%20IBD&rft.jtitle=Inflammatory%20bowel%20diseases&rft.au=Krzystek%E2%80%90Korpacka,%20Malgorzata&rft.date=2008-06&rft.volume=14&rft.issue=6&rft.spage=794&rft.epage=802&rft.pages=794-802&rft.issn=1078-0998&rft.eissn=1536-4844&rft_id=info:doi/10.1002/ibd.20383&rft_dat=%3Cproquest_cross%3E902333841%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4563-73f3dc0adf7e49cbe9d250d34154f977de5d69bc1d51396b734ac22b7ca435ae3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=69202954&rft_id=info:pmid/18213700&rfr_iscdi=true |